Synonyms: glycyl-glycyl-glycyl-L-cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparagyl-L-cysteinyl-L-prolyl-L-lysyl-glycinamide (4->9)-disulfide | Glypressin® | N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin | Terlivaz® | Variquel®
terlipressin is an approved drug (UK (2001), FDA (2022))
Compound class:
Peptide or derivative
Comment: Terlipressin is a clinically used vasopressin analogue. Terlipressin is biotransformed to its active moiety, lysine vasopressin (LVP). It has vasoconstrictive, antihemorrhagic, and antidiuretic properties.
|
Classification ![]() |
|
Compound class | Peptide or derivative |
Approved drug? | Yes (UK (2001), FDA (2022)) |
IUPAC Name ![]() |
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]pyrrolidine-2-carboxamide |
International Nonproprietary Names ![]() |
|
INN number | INN |
5114 | terlipressin |
Synonyms ![]() |
glycyl-glycyl-glycyl-L-cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparagyl-L-cysteinyl-L-prolyl-L-lysyl-glycinamide (4->9)-disulfide | Glypressin® | N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin | Terlivaz® | Variquel® |
Database Links ![]() |
|
CAS Registry No. | 14636-12-5 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL2135460 |
DrugBank Ligand | DB02638 |
DrugCentral Ligand | 2967 |
GtoPdb PubChem SID | 434122301 |
PubChem CID | 72081 |
Search Google for chemical match using the InChIKey | BENFXAYNYRLAIU-QSVFAHTRSA-N |
Search Google for chemicals with the same backbone | BENFXAYNYRLAIU |
Search PubMed clinical trials | terlipressin |
Search PubMed titles | terlipressin |
Search PubMed titles/abstracts | terlipressin |
UniChem Compound Search for chemical match using the InChIKey | BENFXAYNYRLAIU-QSVFAHTRSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | BENFXAYNYRLAIU-QSVFAHTRSA-N |